Physics, Chemistry and Materials Science at the Nanoscale
1Patent Agent, Bawa Biotechnology Consulting, LLC, Ashburn, Virginia, USA; Adjunct Associate Professor, Rensselaer Polytechnic Institute, Troy, New York, USA; Senior Scientist, SynerGene Therapeutics Inc, Potomac, Maryland, USA; Founding Director, American Society for Nanomedicine, Ashburn, Virginia, USA Correspondence: Dr. Raj Bawa, President and Patent Agent, Bawa Biotechnology Consulting, LLC, 21005 Starflower Way, Ashburn, Virginia 20147, USA (Tel: 703-582-1745; 703-723-0034; Fax: 571-223-1844; Email: email@example.com).
Cite as: Raj Bawa MS, PhD. Nanopharmaceuticals NANOPHARMACEUTICALS, nano Online. (2016). DOI: https://doi.org/10.1515/nano.0012.00026
Cite as: Raj Bawa MS, PhD. Nanopharmaceuticals NANOPHARMACEUTICALS, European Journal of Nanomedicine. 3, 34 (2010). DOI: https://doi.org/10.1515/EJNM.2010.3.1.34
THIS ARTICLE WAS ORIGINALLY PUBLISHED IN CLINICAL RESEARCH MANUAL AND APPEARS HERE WITH KIND PERMISSION OF THE PUBLISHERS, EUROMED COMMUNICATIONS, UK
The author declares that there is no conflict of interest and that he has received no payment for preparation of this manuscript. This paper reflects the current views of the author. They should not be attributed, in whole or in part, to the organizations with which he is affiliated, nor should they be considered as expressing an opinion with regard to the merits of any particular company or product discussed herein. Nothing contained herein is to be considered as the rendering of legal advice.